Abbratech Inc
AbbraTech Inc, founded in 2020 in Branford, Connecticut, is a pioneering biotechnology company focused on advancing antibody discovery and engineering. Utilizing their innovative EPIVOLVE technology, they aim to identify antibodies targeting previously inaccessible disease proteins for the treatment of conditions such as cancer and immune disorders.
Composed of a team of experienced scientists in antibody engineering, AbbraTech combines advanced methods such as phage display and B cell cloning to tackle challenging antigen targets. Their mission is to collaborate with industry and academic partners to develop next-generation antibody-based therapies that push the boundaries of current medical approaches.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.